Literature DB >> 1883685

Hemopoietic growth factors and receptors: bound and free.

M Y Gordon1.   

Abstract

Hemopoietic growth factors regulate blood cell production by interacting with specific receptors on hemopoietic progenitor cells. These factors are regarded conventionally as soluble molecules that are freely available to their target cells. There is growing evidence, however, that several of the factors can also exist as biologically active membrane- or matrix-bound entities. Conversely, the receptors for several of the factors, conventionally regarded as membrane-bound molecules, have been shown to exist as soluble entities that retain ligand binding activity. In principle, such soluble receptors could regulate the accessibility of the growth factors to target cells by performing carrier and/or blocking functions. Consideration of these new types of interactions should help us to understand the ways in which target cell responses to multifunctional growth factors can be controlled in vivo.

Mesh:

Substances:

Year:  1991        PMID: 1883685

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  8 in total

1.  Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2.

Authors:  E J Huang; K H Nocka; J Buck; P Besmer
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

2.  Immunoglobulin heavy-chain and CD3 delta-chain gene enhancers are DNase I-hypersensitive in hemopoietic progenitor cells.

Authors:  A M Ford; C A Bennett; L E Healy; E Navarro; E Spooncer; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

3.  Regulation of the spatial organization of mesenchymal connective tissue: effects of cell-associated versus released isoforms of platelet-derived growth factor.

Authors:  S A Eming; M L Yarmush; G G Krueger; J R Morgan
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

4.  Transmembrane kit ligand cleavage does not require a signal in the cytoplasmic domain and occurs at a site dependent on spacing from the membrane.

Authors:  H J Cheng; J G Flanagan
Journal:  Mol Biol Cell       Date:  1994-09       Impact factor: 4.138

5.  Activated release of membrane-anchored TGF-alpha in the absence of cytosol.

Authors:  M W Bosenberg; A Pandiella; J Massagué
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

6.  Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism.

Authors:  J Arribas; J Massagué
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

7.  Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.

Authors:  C Lu; R S Kerbel
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

8.  Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.

Authors:  R G Hawley; A Z Fong; B F Burns; T S Hawley
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.